california dmhc glp-1 coverage exclusion allowed has ended adult Medi-Cal for popular weight loss medications, leaving thousands of patients worried about losing treatment that helped control diabetes, prevent disease and change their Your insurance is betting you'll

100+ biomarkers, physician-interpreted results, and a clear protocol for what comes next.

More than 30 million Americans are using some form of weight loss drug, often with significant results

Conclusion By interrupting the degradation pathways of l-cysteine, serine and GSH and blocking glycogen formation, the GSH production efficiency was significantly improved

Shavlakadze, T

Last reviewed: June 18, 2026 Last updated: June 18, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations